AMAG Pharmaceuticals, Inc announced that the US Food and Drug Administration (FDA) has designated the company's resubmission to the October 2008 Complete Response letter for its New Drug Application (NDA) for ferumoxytol as a complete, class 1 response.
The details can be read here.
No comments:
Post a Comment